What are the new and emerging therapies in myopia control?
Activity Outline
This session will provide an evidence-based approach to myopia control for a range of clinical presentations. We will explore:• atropine with orthokeratology
• atropine with soft multifocal contact lenses
• peripheral defocus spectacle lenses
• repeated low-level red-light therapy
Myopia management – What happens when the children are all grown up?
Presented by Joe Tanner - Head of Professional Affairs, CooperVision AUNZ
Myopia management studies typically focus on children but myopia often progresses into the late teens and beyond. We need to understand how treatments given to young patients cope with the changing lifestyles and needs that come with maturity. This presentation reviews what happens when children wearing MiSight 1 day for myopia management reach adulthood.
Learning Objectives
- Describe the new and emerging evidence-based treatments available for myopia control
- Understand the effect of long-term full-time contact lens wear on the corneas of children fitted with MiSight 1 day
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| What are the new and emerging therapies in myopia control? |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2 |